MX9706944A - Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. - Google Patents
Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p.Info
- Publication number
- MX9706944A MX9706944A MX9706944A MX9706944A MX9706944A MX 9706944 A MX9706944 A MX 9706944A MX 9706944 A MX9706944 A MX 9706944A MX 9706944 A MX9706944 A MX 9706944A MX 9706944 A MX9706944 A MX 9706944A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- halo
- disturbances
- hydrogen
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invencion proporciona un compuesto de formula (I): y sus sales farmacéuticamente aceptables, en la que R1 es halo, alquilo C1-C6, halo (alquilo C1-C6), alcoxi C1-C6 o halo (alcoxi C1-C6); R2 es hidrogeno, alquilo C1-C6, halo(alquilo C1-C6), (alquilo C1-C6)-S- (alquilo C1-C6)-SO-, (alquilo C1-C6)-SO2-, ciclopropilo, fenilo, -NH2-, -NH(CH3),-NHC(=O)CH3, -N(CH3)2, -N(c2H5) o -CH2C(=O)CF3; Ar1 y Ar2 son independientemente fenilo, halofenilo o tienilo; X es NH, O u S; e Y es hidrogeno, -COOR3 o -CON-R4R5, en los que R3, R4 y R5 son independientemente hidrogeno o alquilo C1-C6; estos compuestos son utiles como agentes analgésicos o antiinflamatorios, o en el tratamiento de trastornos alérgicos, angiogénesis, trastornos del SNC, emesis, trastornos gastrointestinales, quemaduras solares, incontinencia urinaria o enfermedades, trastornos o estados adversos provocados por Helicobacter pylori, o similares, en un sujeto mamífero, especialmente en un ser humano, especialmente como agentes analgésicos y antiinflamatorios en la periferia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB9600934 | 1996-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9706944A true MX9706944A (es) | 1998-08-30 |
Family
ID=11004477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9706944A MX9706944A (es) | 1996-09-12 | 1996-09-12 | Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5939434A (es) |
| EP (1) | EP0829480B1 (es) |
| JP (1) | JP3273750B2 (es) |
| AT (1) | ATE198201T1 (es) |
| CA (1) | CA2215020C (es) |
| DE (1) | DE69703725T2 (es) |
| DK (1) | DK0829480T3 (es) |
| ES (1) | ES2152633T3 (es) |
| GR (1) | GR3035379T3 (es) |
| MX (1) | MX9706944A (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) * | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US20040142929A1 (en) * | 2001-07-06 | 2004-07-22 | Ramon Merce-Vidal | Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
| US6861526B2 (en) | 2002-10-16 | 2005-03-01 | Pfizer Inc. | Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine |
| CA2531573C (en) | 2003-08-01 | 2010-04-13 | Toyo Kasei Kogyo Company Limited | Alkoxy-(tetrazol-1-yl)benzaldehyde compound and process for producing the same |
| WO2005045395A2 (en) * | 2003-10-27 | 2005-05-19 | Meyer Donald W | Method of detecting bovine spongiform encephalopathy |
| JP5172124B2 (ja) | 2006-09-29 | 2013-03-27 | 関東化学株式会社 | ２位に置換基を有する光学活性キヌクリジノール類の製造方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680283A (en) * | 1984-09-26 | 1987-07-14 | Merck & Co., Inc. | Analogs of substance P and eledoisin |
| MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
| DE69220258T2 (de) * | 1991-02-11 | 1997-12-18 | Merck Sharp & Dohme | Azabicyclische Verbindungen, diese enthaltende pharmazeutische Zubereitungen und ihre therapeutische Verwendung |
| AU658898B2 (en) * | 1991-05-22 | 1995-05-04 | Pfizer Inc. | Substituted 3-aminoquinuclidines |
| US5716965A (en) * | 1991-05-22 | 1998-02-10 | Pfizer Inc. | Substituted 3-aminoquinuclidines |
| US5288730A (en) * | 1991-06-24 | 1994-02-22 | Merck Sharp & Dohme Limited | Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| EP0533280B2 (en) * | 1991-09-20 | 2004-12-01 | Glaxo Group Limited | Novel medical use for tachykinin antagonists |
| US5569662A (en) * | 1992-03-23 | 1996-10-29 | Pfizer Inc. | Quinuclidine derivatives as substance P antagonists |
| JP2656702B2 (ja) * | 1992-03-23 | 1997-09-24 | ファイザー製薬株式会社 | ペプチド性キヌクリジン |
| US5604241A (en) * | 1992-10-21 | 1997-02-18 | Pfizer Inc. | Substituted benzylaminoquinuclidines as substance P antagonists |
| JP2656700B2 (ja) * | 1992-10-28 | 1997-09-24 | ファイザー製薬株式会社 | 置換キヌクリジン誘導体 |
| IL109646A0 (en) * | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
| US5869499A (en) * | 1993-07-15 | 1999-02-09 | Pfizer Inc | Benzyloxyquinuclidines as substance P antagonists |
| IL111002A (en) * | 1993-09-22 | 1998-09-24 | Glaxo Group Ltd | History of piperidine, their preparation and the pharmaceutical preparations containing them |
-
1996
- 1996-09-12 MX MX9706944A patent/MX9706944A/es active IP Right Grant
-
1997
- 1997-08-28 AT AT97306612T patent/ATE198201T1/de not_active IP Right Cessation
- 1997-08-28 ES ES97306612T patent/ES2152633T3/es not_active Expired - Lifetime
- 1997-08-28 DK DK97306612T patent/DK0829480T3/da active
- 1997-08-28 DE DE69703725T patent/DE69703725T2/de not_active Expired - Fee Related
- 1997-08-28 EP EP97306612A patent/EP0829480B1/en not_active Expired - Lifetime
- 1997-09-05 US US08/924,171 patent/US5939434A/en not_active Expired - Fee Related
- 1997-09-10 CA CA002215020A patent/CA2215020C/en not_active Expired - Fee Related
- 1997-09-11 JP JP26296597A patent/JP3273750B2/ja not_active Expired - Fee Related
-
2001
- 2001-02-07 GR GR20010400206T patent/GR3035379T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US5939434A (en) | 1999-08-17 |
| EP0829480A3 (en) | 1998-04-08 |
| GR3035379T3 (en) | 2001-05-31 |
| JPH1087661A (ja) | 1998-04-07 |
| DE69703725T2 (de) | 2001-04-26 |
| CA2215020A1 (en) | 1998-03-12 |
| DK0829480T3 (da) | 2001-02-19 |
| JP3273750B2 (ja) | 2002-04-15 |
| EP0829480A2 (en) | 1998-03-18 |
| ES2152633T3 (es) | 2001-02-01 |
| CA2215020C (en) | 2000-05-16 |
| ATE198201T1 (de) | 2001-01-15 |
| DE69703725D1 (de) | 2001-01-25 |
| EP0829480B1 (en) | 2000-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20074166B (en) | Acetyl 2-hydroxy-1,3 diaminoalkanes | |
| CA2396738A1 (en) | Thiazole derivatives as active superoxide radical inhibitors | |
| CA2079485A1 (en) | Chelator compositions comprising oxime compounds | |
| CA2313122A1 (en) | Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents | |
| MY128063A (en) | Aromatic heterocyclic compound as antiinflammatory agents | |
| MY125359A (en) | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods. | |
| ATE168992T1 (de) | 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline | |
| BG101112A (en) | The use of heterocyclic compounds | |
| NZ237565A (en) | Substituted thiazolidinones, oxazolidinones or imidazolidinones and antiinflammatory pharmaceutical compositions thereof | |
| MX9700340A (es) | Agentes anti-helicobacter derivados sulfonamida de azolonas. | |
| HK1040985A1 (en) | Cell adhesion-inibiting antiinflammatory and immunesuppressive compounds. | |
| EP1184373A4 (en) | TRICYCLIC CONNECTIONS | |
| MX9706944A (es) | Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. | |
| AU5390900A (en) | Potassium channel blocking agents | |
| EP1121932A4 (en) | DRUGS FOR EYE DISEASES | |
| NO964216D0 (no) | Ester- og karbamatderivater av azoloner som er kraftige midler mot Helicobacter | |
| WO2000071538A3 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
| PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
| SE9704770D0 (sv) | New use | |
| AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
| NO303686B1 (no) | Forbindelse til anvendelse ved fremstilling av alkylderivater av trazodon med CNS-aktivitet | |
| CA2309485A1 (en) | New 4-arylpiperidine derivatives for the treatment of pruritus | |
| TNSN05067A1 (en) | Acetyl 2-hydroxy- 1,3 diaminoalkanes | |
| PT1049670E (pt) | Derivados de azetidinocarboxamida para o tratamento de perturbacoes do snc | |
| TW429147B (en) | Pharmaceutical composition for the treatment of CNS disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |